Search research articles
Contact Us
Filters
Showing results (21-30 of 66) with videos related to
Page
of 7
Sort By:
Cancer Research
|
May 3, 2006
Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death
Lonnie P Swift, Ada Rephaeli, Abraham Nudelman, et al.
European Journal of Medicinal Chemistry
|
December 17, 2010
Structure--activity relationship studies of 1-(4-chloro-2,5-dimethoxyphenyl)-3-(3-propoxypropyl)thiourea, a non-nucleoside reverse transcriptase inhibitor of human immunodeficiency virus type-1
Michal Weitman, Keti Lerman, Abraham Nudelman, et al.
Molecular Cancer Therapeutics
|
July 29, 2003
Sequence specificity of adriamycin-DNA adducts in human tumor cells
Suzanne M Cutts, Lonnie P Swift, Ada Rephaeli, et al.
Journal of Medicinal Chemistry
|
April 27, 2007
De novo parallel design, synthesis and evaluation of inhibitors against the reverse transcriptase of human immunodeficiency virus type-1 and drug-resistant variants
Alon Herschhorn, Lena Lerman, Michal Weitman, et al.
Molecular Cancer Therapeutics
|
February 18, 2003
Activation of adriamycin by the pH-dependent formaldehyde-releasing prodrug hexamethylenetetramine
Lonnie P Swift, Suzanne M Cutts, Ada Rephaeli, et al.
Cancer Letters
|
July 6, 2007
The anticancer prodrugs of butyric acid AN-7 and AN-9, possess antiangiogenic properties
Diana Blank-Porat, Tal Gruss-Fischer, Nataly Tarasenko, et al.
Cancer Biology & Therapy
|
July 25, 2003
Mitoxantrone mediates demethylation and reexpression of cyclin d2, estrogen receptor and 14.3.3sigma in breast cancer cells
Belinda S Parker, Suzanne M Cutts, Abraham Nudelman, et al.
Cancer Letters
|
March 10, 2007
AN-113, a novel prodrug of 4-phenylbutyrate with increased anti-neoplastic activity in glioma cell lines
Michal Entin-Meer, Ada Rephaeli, Xiaodong Yang, et al.
Oncology Research
|
May 5, 2009
Development of pluronic micelle-encapsulated doxorubicin and formaldehyde-releasing prodrugs for localized anticancer chemotherapy
Michal Ugarenko, Chee-Kai Chan, Abraham Nudelman, et al.
Biochemical Pharmacology
|
September 10, 2009
ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts
Michal Ugarenko, Abraham Nudelman, Ada Rephaeli, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 66) with videos related to
Sort By:
Page
of 7
Cancer Research
|
May 3, 2006
Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death
Lonnie P Swift, Ada Rephaeli, Abraham Nudelman, et al.
European Journal of Medicinal Chemistry
|
December 17, 2010
Structure--activity relationship studies of 1-(4-chloro-2,5-dimethoxyphenyl)-3-(3-propoxypropyl)thiourea, a non-nucleoside reverse transcriptase inhibitor of human immunodeficiency virus type-1
Michal Weitman, Keti Lerman, Abraham Nudelman, et al.
Molecular Cancer Therapeutics
|
July 29, 2003
Sequence specificity of adriamycin-DNA adducts in human tumor cells
Suzanne M Cutts, Lonnie P Swift, Ada Rephaeli, et al.
Journal of Medicinal Chemistry
|
April 27, 2007
De novo parallel design, synthesis and evaluation of inhibitors against the reverse transcriptase of human immunodeficiency virus type-1 and drug-resistant variants
Alon Herschhorn, Lena Lerman, Michal Weitman, et al.
Molecular Cancer Therapeutics
|
February 18, 2003
Activation of adriamycin by the pH-dependent formaldehyde-releasing prodrug hexamethylenetetramine
Lonnie P Swift, Suzanne M Cutts, Ada Rephaeli, et al.
Cancer Letters
|
July 6, 2007
The anticancer prodrugs of butyric acid AN-7 and AN-9, possess antiangiogenic properties
Diana Blank-Porat, Tal Gruss-Fischer, Nataly Tarasenko, et al.
Cancer Biology & Therapy
|
July 25, 2003
Mitoxantrone mediates demethylation and reexpression of cyclin d2, estrogen receptor and 14.3.3sigma in breast cancer cells
Belinda S Parker, Suzanne M Cutts, Abraham Nudelman, et al.
Cancer Letters
|
March 10, 2007
AN-113, a novel prodrug of 4-phenylbutyrate with increased anti-neoplastic activity in glioma cell lines
Michal Entin-Meer, Ada Rephaeli, Xiaodong Yang, et al.
Oncology Research
|
May 5, 2009
Development of pluronic micelle-encapsulated doxorubicin and formaldehyde-releasing prodrugs for localized anticancer chemotherapy
Michal Ugarenko, Chee-Kai Chan, Abraham Nudelman, et al.
Biochemical Pharmacology
|
September 10, 2009
ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts
Michal Ugarenko, Abraham Nudelman, Ada Rephaeli, et al.
Page
of 7